Cox Capital Management
AQST icon

Cox Capital Management’s Aquestive Therapeutics AQST Stock Holding History

Cox Capital Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$48.6K Hold
10,500
– – 0.03% 74
2026
Q2 		$43.7K Hold
10,500
– – 0.02% 81
2026
Q1 		$43.6K Hold
10,500
– – 0.03% 73
2025
Q4 		$35.9K Hold
10,500
– – 0.02% 62
2025
Q3 		$58.7K Buy
+10,500
New +$45.4K 0.04% 61

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $45.4M AUM 17.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Propel Bio Management
Propel Bio Management Los Angeles, California $189M AUM 71.31% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Blue Owl Capital Holdings
Blue Owl Capital Holdings New York $548M AUM 35.34% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $52.3B AUM 19.7% 1-Year Est. Return

Cox Capital Management's AQST Position: Q3 2026 in Review

Cox Capital Management held its Aquestive Therapeutics (AQST) position steady in Q3 2026 at 10,500 shares worth $48.6K. The position accounts for 0.03% of the portfolio, ranked #74.

Cox Capital Management first reported a position in AQST in Q3 2025 and has held it in 5 quarters since. The position peaked at $58.7K in Q3 2025. 142 funds tracked by Wall St. Rank hold AQST as of Q3 2026.

  • Cox Capital Management held 10,500 shares of Aquestive Therapeutics worth $48.6K as of Q3 2026.
  • Cox Capital Management left its Aquestive Therapeutics share count unchanged in Q3 2026.
  • Aquestive Therapeutics made up 0.03% of Cox Capital Management's portfolio in Q3 2026, its #74 holding.
  • Cox Capital Management first reported a position in Aquestive Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Cox Capital Management's Aquestive Therapeutics position peaked at $58.7K in Q3 2025.
  • 142 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.

Based on Cox Capital Management's 13F filing for Q3 2026, filed 7 Oct 2026.